MannKind to Report First Quarter 2026 Financial Results on May 6, 2026

Rhea-AI Summary

MannKind (Nasdaq: MNKD) will report first quarter 2026 financial results on May 6, 2026, after market close. A live webcast to review results and provide a business update will begin at 4:30 p.m. Eastern Time.

According to the company, the webcast link will be available on MannKind’s investor website, with a replay posted within 24 hours and accessible for about 90 days.

News Market Reaction – MNKD

+2.91%

+2.91% Session close to close

In the Apr 30 session, MNKD gained 2.91%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timing for MannKind’s Q1 2026 results on May 6, 2026, with a webcast at 4...

Analysis

This announcement sets the timing for MannKind’s Q1 2026 results on May 6, 2026, with a webcast at 4:30 p.m. ET and replay access for about 90 days. Historically, a prior earnings-date notice led to a modest -1.81% move, while the actual Q4/FY 2025 report coincided with a larger decline. Investors may focus on how Q1 results relate to recent revenue growth, product performance, and upcoming regulatory milestones.

Key Figures

Earnings release date: May 6, 2026 Webcast time: 4:30 p.m. Eastern Time Replay availability: Within 24 hours +1 more

4 metrics

Earnings release date May 6, 2026 Planned release of Q1 2026 financial results after market close

Webcast time 4:30 p.m. Eastern Time Start time of Q1 2026 results webcast

Replay availability Within 24 hours Replay posted after the earnings webcast

Replay duration Approximately 90 days Length of time webcast replay will remain accessible

Previous Earnings date Reports

1 past event · Latest: Feb 18 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 18	Earnings date notice	Neutral	-1.8%	Announcement of Q4 and full-year 2025 results release timing and webcast details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The prior earnings-date announcement saw a modest negative move of -1.81%, suggesting past earnings-date headlines have not driven strong upside reactions.

Recent Company History

Over recent months, MannKind has combined operational updates with financial milestones. The last earnings-date notice on Feb 18, 2026 preceded a -1.81% move, while the subsequent Q4/FY 2025 results release on Feb 26, 2026 coincided with a -7.43% reaction despite revenue growth. Against this backdrop, the new Q1 2026 earnings-date announcement continues the pattern of scheduled updates with webcasts and replay access for investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung diseases, announced today that it will report its first quarter 2026 financial results on Wednesday, May 6, 2026, after market close.

The company will host a webcast beginning at 4:30 p.m. Eastern Time to review the financial results and provide a business update.

The webcast will be accessible via a link on MannKind’s website at https://investors.mannkindcorp.com/events-and-presentations. A replay will be available in the same location within 24 hours following the call and will be accessible for approximately 90 days.

About MannKind
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.

Learn more at mannkindcorp.com. 

Contacts:
Investor Relations
Kate Miranda
Email: ir@mnkd.com

Media Relations
Christie Iacangelo
Email: media@mnkd.com

FAQ

When will MannKind (MNKD) report its Q1 2026 financial results?

MannKind will report Q1 2026 results on May 6, 2026, after market close via webcast. According to the company, the webcast will review financial results and provide a business update beginning at 4:30 p.m. Eastern Time.

What time is the MannKind (MNKD) Q1 2026 webcast on May 6, 2026?

The MannKind webcast will begin at 4:30 p.m. Eastern Time on May 6, 2026 to review results. According to the company, the session follows the after-market release and will include a business update and Q&A as available.

How can investors access the MannKind (MNKD) May 6, 2026 webcast?

Investors can access the webcast via a link on MannKind’s investor website listed for events and presentations. According to the company, the link will be active at the scheduled start time and accessible from the investor relations events page.

Will a replay of the MannKind (MNKD) Q1 2026 webcast be available?

A replay will be posted within 24 hours after the webcast and remain available for approximately 90 days. According to the company, the replay will be accessible at the same investor relations events-and-presentations web location.

What will MannKind (MNKD) cover during the May 6, 2026 webcast?

The webcast will review first quarter 2026 financial results and provide a business update, per the company. According to the company, the presentation will discuss results and related corporate developments for investors.